Scoring tool to identify patients at increased risk for drug-related problems: results of a point prevalence study at hospital admission

被引:1
作者
Berger, Saskia [1 ,2 ]
Hilgarth, Heike [3 ]
Fischer, Andreas [1 ]
Remane, Yvonne [4 ]
Schmitt, Jochen [2 ]
Knoth, Holger [1 ]
机构
[1] Tech Univ Dresden, Klin Apotheke, Univ Klinikum Carl Gustav Carus, Dresden, Germany
[2] Tech Univ Dresden, Zent Evidenzbasierte Gesundheitsversorgung ZEGV, Univ Klinikum Carl Gustav Carus, Dresden, Germany
[3] Bundesverband Deutsch Krankenhausapotheker eV ADKA, Berlin, Germany
[4] Univ Klinikum Leipzig, Klin Apotheke, Leipzig, Germany
关键词
Risiko Score; Arzneimittel-bezogene Probleme; Krankenhaus; Apotheker:innen; Aufnahmemanagement; MEDICATION ERRORS; PHARMACY;
D O I
10.1055/a-2161-2655
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
<bold>Introduction: </bold>Drug therapy is a high-risk process and requires special attention, especially at sectoral borders. Pharmaceutical services such as medication review are appropriate measures to identify drug-related problems and thus improve the safety of drug therapy. Risk-scoring tools have been described in the literature as helpful for prioritizing medication reviews for patients at high risk for drug-related problems.<bold>Methods: </bold>In a multi-centre point prevalence study, we identified patients at increased risk for medication-related problems at hospital admission using the medication risk tool. In addition, the current level of implementation of pharmacy services was surveyed.<bold>Results: </bold>A total of 11 (58%; 11/19) hospital pharmacies in Saxony participated in the point prevalence survey. The scoring tool identified 32% (279/875) of patients at increased risk for medication-related problems (Meris score >12 group) at admission. Thereby, the number of drugs in the Meris score >12 group was 10.6 (average; standard deviation 3.5; n=279), while in the Meris score <= 12 group it was only five drugs per patient (average 4.6; standard deviation 2.8; n=596). The age of patients in the Meris score >12 group averaged 75.9 +/- 11 years, while the age of patients in the Meris score <= 12 group averaged 60.6 +/- 17.9 years.<bold>Discussion: </bold>Prioritization with the help of a risk-scoring tool is essential as pharmacy services in Saxon hospitals still need to be regularly established and in order to identify patients with an increased risk for drug-related problems at an early stage.
引用
收藏
页码:E113 / E119
页数:7
相关论文
共 31 条
  • [1] aezq, SOP MED REC
  • [2] Aly A.-F., 2015, AVP, V43, P99
  • [3] How complete is the Germany-wide standardised medication list ("Bundeseinheitlicher Medikationsplan")? An analysis at hospital admission.
    Amelung, Stefanie
    Bender, Bianca
    Meid, Andreas
    Walk-Fritz, Stefanie
    Hoppe-Tichy, Torsten
    Haefeli, Walter E.
    Seidling, Hanna M.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (21) : E116 - E122
  • [4] [Anonymous], STAT BUNDESAMT DESTA
  • [5] Effects of stratified medication review in high-risk patients at admission to hospital: a randomised controlled trial
    Bonnerup, Dorthe Krogsgaard
    Lisby, Marianne
    Saedder, Eva Aggerholm
    Brock, Birgitte
    Truelshoj, Tania
    Sorensen, Charlotte Arp
    Pedersen, Anita Gorm
    Nielsen, Lars Peter
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [6] Impact of a Clinical Pharmacy Admission Medication Reconciliation Program on Medication Errors in "High-Risk" Patients
    Buckley, Mitchell S.
    Harinstein, Lisa M.
    Clark, Kimberly B.
    Smithburger, Pamela L.
    Eckhardt, Doug J.
    Alexander, Earnest
    Devabhakthuni, Sandeep
    Westley, Craig A.
    David, Butch
    Kane-Gill, Sandra L.
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (12) : 1599 - 1610
  • [7] Ciapponi A, 2021, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009985.pub2, 10.1002/14651858,CD009985.pub2]
  • [8] egam, EMPFEHLUNGEN ZUM UMG
  • [9] EAHP Survey 2010 on hospital pharmacy in Europe: Part 1. General frame and staffing
    Frontini, Roberto
    Miharija-Gala, Tajda
    Sykora, Juraj
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2012, 19 (04): : 385 - 387
  • [10] Grandt D., 2022, KRANKENHAUSPHARMAZIE, P91